Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report FindsPRNewsWire • 05/13/25
Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in FocusZacks Investment Research • 05/05/25
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 EarningsBenzinga • 04/23/25
Quest Diagnostics Looks Like A 'Safe Haven' After First-Quarter BeatInvestors Business Daily • 04/22/25
Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarterMarket Watch • 04/22/25
Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025PRNewsWire • 04/22/25
Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 04/15/25
Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's DiseasePRNewsWire • 04/09/25
T-Mobile Leads Five Stocks To Watch As Market Correction IntensifiesInvestors Business Daily • 04/05/25
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer ScreeningPRNewsWire • 04/02/25
Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025PRNewsWire • 04/01/25
Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the SpotlightZacks Investment Research • 03/19/25
Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor DayPRNewsWire • 03/19/25